Triple Therapy with Ranitidine, Clarithromycin, and Metronidazole in the Treatment of Helicobacter pylori

References

• Dooley C P, Cohen H, Fitzgibbons P L, Bauer M, Appleman M D, Perez-Perez G I, et al. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321: 1562–6
   PubMed Web of Science ®Google Scholar
• Marshall B J, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311–3
   Google Scholar
• Blaser M I. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990; 161: 626–33
   PubMed Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R. Prospective double blind trial of duodenal ulcer relapse after eradication of Helicobacter pylori. Lancet 1988; ii: 1437–42
   Google Scholar
• Axon A T. Duodenal ulcer: the villain unmasked? Eradicating Helicobacter pylon will cure most patients. Br Med J 1991; 302: 919–21
   PubMed Web of Science ®Google Scholar
• Graham D Y. Treatment of peptic ulcers caused by Helicobacter pylori. N Engl J Med 1993; 328: 349–50
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Friedman G D, Vandersteen D P, Chang Y, Vogelman J H, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
   PubMed Web of Science ®Google Scholar
• The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359–62
   PubMed Web of Science ®Google Scholar
• Hanson L-E, Engstrand L, Nyren O, Evans D J, Lindgren A, Bergström R, et al. Helicobacter pylori infection independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098–103
   PubMed Web of Science ®Google Scholar
• Hussell T, Isaacson P G, Crabtree J E, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993; 342: 571–4
   PubMed Web of Science ®Google Scholar
• Wotherspoon A C, Doglioni C, Diss T C, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575–7
   PubMed Web of Science ®Google Scholar
• Stolte M, Eidt S. Healing gastric MALT lymphomas by eradicating H. pylori?. Lancet 1993; 342: 568
   PubMedGoogle Scholar
• Rauws E A, Langenberg W, Houthoff H J, Zanen H C, Tytgat G N. Campylobacter pyloridis-associated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33–40
   PubMedGoogle Scholar
• Goodwin C S, Armstrong J A, Marshall B J. Campylobacter pyloridis, gastritis and peptic ulceration. J Clin Pathiol 1986; 39: 353–65
   PubMed Web of Science ®Google Scholar
• Moss S, Calam J. Helicobacter pylori and peptic ulcers the present position. Gut 1992; 33: 289–92
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G M, Evans D G, Evans D J, Klein P D. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med 1991; 115: 266–9
   PubMed Web of Science ®Google Scholar
• Noach L A, Bertola M A, Schwarz M P, Rauws E A, Tytgat G N. Treatment of Helicobacter pylori infection: an evaluation of various therapeutic trials and review of the literature. Thesis, Amsterdam University, Amsterdam 1993
   Google Scholar
• Marshall B J, Armstrong J A, Francis G J, Nokes N T, Wee S H. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 1987; 73: 16–30
   Google Scholar
• Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990; 85: 1545–51
   PubMed Web of Science ®Google Scholar
• O'Riordan T, Mathai E, Tobui E, McKenna D, Keane C, Sweeney E, et al. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990; 31: 999–1002
   PubMed Web of Science ®Google Scholar
• McNulty C AM, Gearty J C, Crump B, et al. Campylobacter pyloridis and associated gastritis: investigator blind, placebo-controlled trial of bismuth salicylate and erythromycin ethyl-succinate. Br Med J 1986; 293: 645–9
   PubMed Web of Science ®Google Scholar
• Wagner S, Freise J, Bär W, Fritsch S, Schmidt F M. Epidemiologie und Therapie der Campylobacter-pylori Infection. Dtsch Med Wschr 1989; 114: 407–13
   PubMedGoogle Scholar
• De Koster E, Nyst J F, Deprez C, Glupczynski Y, Jonas C, Denis P, et al. Hp treatment; disappointing results with amoxillin plus omeprazole ‘Abstract’. Ital J Gastroenterol 1991; 23(Suppl 2)105
   Google Scholar
• Logan R PH, Rubio M A, Gummett P A, Hegarty B, Walker M M, Baron J H, et al. Omeprazole and amoxycyllin suspension for Helicobacter pylori ‘Abstract’. Ir J Med Sci 1992; 161(Suppl 10)16
   PubMed Web of Science ®Google Scholar
• Borody T J, Cole P, Noonan S, Morgan A, Lenne J, Hyland L, et al. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151: 431–5
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G M, Malaty H M, Evans D G, Klein P D. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–6
   PubMed Web of Science ®Google Scholar
• Suerbaum S, Leying H, Klemm K, Opferkuch W. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991; 10: 92–3
   PubMed Web of Science ®Google Scholar
• Loo V G, Sherman P, Matlow A G. Helicobacter pylori infection in a pediatric population: in vitro susceptibilities to omeprazole and eight antimicrobial agents. Antimicrob Agents Chemother 1992; 36: 1133–5
   PubMedGoogle Scholar
• Fiocca R, Vitlani L, Luinetti O, Gianatti A, Boldorine R, Lazzaroni M, et al. Helicobacter pylori eradication and sequential clearance of inflammation in duodenal ulcer patients treated with omeprazole and antibiotics ‘Abstract’. Ir J Med Sci 1992; 161(Suppl 10)93–4
   Google Scholar
• Lamouliatte H, Bernard P H, Cayla F, Megraud F, de Mascarel A, Quinton A. Controlled study of omeprazole-amoxicillin-tinidazole vs ranitidine-amoxicillin-tinidazole in Helicobacter pylori associated duodenal ulcers (DU). Final and long-term results ‘Abstract’. Gastroenterology 1992; 102: A106
   Google Scholar
• Hentschel E, Brandstätter G, Dragosics B, Hirschl A M, Nemec H, Schutze K, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308–12
   PubMed Web of Science ®Google Scholar
• Price A B. The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209–22
   PubMed Web of Science ®Google Scholar
• Veenendaal R A, Lichtendahl-Bernards A T, Peña A S, Endtz H Ph, van Duijn W, van Boven C P, et al. Influence of transport medium and transportation time on culture of Helicobacter pylori from gastric biopsies. J Clin Path 1993; 46: 561–3
   PubMed Web of Science ®Google Scholar
• Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 1988; 41: 207–10, Goodwin C. S., Marshall B. J., Blincow
   PubMed Web of Science ®Google Scholar
• Goodwin C S, Warsley B W. Microbiology of Helicobacter pylori. Gastroenterol Clin North Am 1993; 22: 5–19
   PubMed Web of Science ®Google Scholar